房颤导管消融与抗心律失常药物后复发的性别差异
研究纳入2999例首次房颤导管消融患者,比较复发后抗心律失常药物反应的性别差异。女性首次消融后心律结局较差,但术后复发后药物反应优于男性,尤其60岁以上女性。
要点
- 女性首次房颤消融后复发风险高于男性。
- 术后复发后抗心律失常药物反应女性优于男性。
- 60岁以上女性术后药物反应优势更明显。
核心结论
- 女性首次房颤消融后心律结局较男性差,但术后复发后抗心律失常药物反应女性优于男性,尤其60岁以上女性。
研究设计与样本
- 连续纳入2999例首次房颤消融患者,女性占26.5%,年龄58.3±10.9岁,阵发性房颤占68.1%。
- 在1094例复发患者及788例后续接受抗心律失常药物节律控制患者中比较性别差异。
主要发现
- 随访48.2±34.9个月,1094例(36.5%)首次消融后房颤复发。
- 788例接受抗心律失常药物患者中508例(64.5%)房颤复发。
- 女性首次消融后心律结局较差(log-rank p=0.041,HR 1.28,95%CI 1.02至1.59,p=0.031)。
- 术后复发后抗心律失常药物反应女性优于男性(log-rank p=0.003,HR 0.75,95%CI 0.59至0.95,p=0.022)。
- 60岁以上女性药物反应优势更明显(log-rank p=0.003)。
关键数值与推荐
- 249例药物后重复手术患者中,女性肺静脉重新连接率低于男性(62.7% vs 76.8%,p=0.048)。
- 肺静脉外触发灶存在率性别间无差异(37.8% vs 25.4%,p=0.169)。
临床怎么用
- 女性首次消融后应关注较高复发风险,术后复发时可考虑抗心律失常药物节律控制,尤其60岁以上女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The risk of recurrence after atrial fibrillation (AF) catheter ablation (AFCA) is higher in women than in men. However, it is unknown whether a sex difference exists in antiarrhythmic drug (AAD) responsiveness among patients with recurrence. METHODS: Among 2999 consecutive patients (26.5% women, 58.3±10.9 years old, 68.1% paroxysmal AF) who underwent de novo AFCA, we compared and evaluated the sex differences in rhythm outcome in 1094 patients with recurrence and in 788 patients who subsequently underwent rhythm control with AAD. RESULTS: During a follow-up of 48.2±34.9 months, 1094 patients (36.5%) had AF recurrence after AFCA, and 508 of 788 patients (64.5%) had AF recurrence under AAD. Although the rhythm outcome of a de novo AFCA was worse (log-rank p=0.041, HR 1.28, 95% CI 1.02 to 1.59), p=0.031) in women, AAD response after postprocedural recurrences was better in women than in men (log-rank p=0.003, HR 0.75, 95% CI 0.59 to 0.95, p=0.022), especially in women older than 60 years old (log-rank p=0.003). In 249 patients who underwent repeat procedure after AAD use, the pulmonary vein (PV) reconnection rate (62.7% vs 76.8%, p=0.048) was lower in women than in men but not the existence of extra-PV trigger (37.8% vs 25.4%, p=0.169). CONCLUSIONS: Although women showed worse rhythm outcomes than men after AFCA, the post-AFCA AAD response was better in elderly women than in men. TRIAL REGISTRATION NUMBER: NCT02138695.
引用
- Park YJ, Park JW, Yu HT, et al. Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs. Heart. 2023. PMID: 35332048. doi:10.1136/heartjnl-2021-320601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。